Petroclival Meningioma
Deep meningiomas against the brainstem, where planned partial removal with focused radiation preserves function better than complete removal.
Quick Answer
A petroclival meningioma arises deep at the base of the skull, at the junction where the temporal bone meets the clivus, growing against the brainstem and among the nerves controlling facial sensation, eye movement, hearing, and swallowing. These are among the most technically demanding tumors in neurosurgery. Symptoms develop slowly over years — facial numbness, unsteadiness, double vision, hearing loss. Complete removal is frequently not the goal: because the tumor grows among nerves that cannot be sacrificed, planned removal of most of the tumor followed by focused radiation to what remains usually produces better long-term function than attempting to take everything.
Key Takeaways
- These tumors arise deep at the skull base, against the brainstem and among several cranial nerves.
- Symptoms develop slowly over years and commonly include facial numbness, unsteadiness, double vision, and hearing loss.
- They are among the most technically demanding tumors in neurosurgery.
- Complete removal is often not the goal — planned partial removal with focused radiation to the remainder usually preserves function better.
- Judgment about when to stop is as important as surgical technique.
- Several different approaches are used, chosen according to where the tumor extends.
At a Glance
| Where it arises | At the junction of the temporal bone and the clivus, against the brainstem |
|---|---|
| Typical first symptom | Facial numbness, unsteadiness, or double vision developing over years |
| Key structures at risk | The brainstem, the nerves for facial sensation, eye movement, hearing, and swallowing, and the basilar artery |
| Imaging emphasis | MRI with contrast and fine bone imaging; assessment of brainstem interface and vessel involvement |
| Usual approach | Retrosigmoid, transpetrosal, or a combined approach depending on extension |
| Extent of removal | Deliberately partial in many cases, preserving cranial nerve function |
| Role of radiation | Focused radiation to residual tumor is a planned part of treatment, not a fallback |
| Outlook | Long-term control is generally good; the emphasis is on preserving function |
This page focuses specifically on Petroclival Meningioma. For a broader look at meningiomas—including grades, symptoms, diagnosis and treatment options—visit our Meningioma overview
Symptoms
These tumors grow slowly in a crowded space, and the brain and nerves accommodate them for a long time. Symptoms therefore accumulate gradually over years, and patients often cannot date their onset. Numbness, tingling, or altered sensation on one side of the face is among the most common early symptoms, because the nerve carrying facial sensation runs directly across the tumor’s usual site of origin. Some patients instead develop sharp, electric facial pain triggered by touch, chewing, or cold, which can be indistinguishable from Trigeminal neuralgia from other causes — and which in this setting has a tumor behind it. Unsteadiness and difficulty walking in the dark or on uneven ground are common, from pressure on the brainstem and cerebellum. Patients often describe having become cautious rather than having become dizzy.
Double vision, particularly on looking to one side, occurs when the nerve controlling outward eye movement is stretched. Hearing loss and ringing on one side occur as the tumor reaches the hearing nerve. Weakness of facial movement is less common and usually occurs later in the course. Difficulty swallowing, a hoarse voice, and, when the tumor becomes large enough to obstruct the flow of spinal fluid, headache and nausea from raised pressure in the head.
Common Reasons for Evaluation
- Double vision or difficulty moving one eye
- Facial numbness, tingling, or pain
- Hearing loss, ringing in the ear, or imbalance
- Progressive difficulty swallowing or changes in voice
- Increasing unsteadiness or coordination problems
Symptoms That Need Prompt Evaluation
- Sudden or rapidly worsening weakness or difficulty walking
- New severe swallowing difficulty or choking
- Sudden major vision or eye-movement changes
- New severe confusion, loss of consciousness, or other rapidly developing neurologic symptoms
Diagnosis
MRI with contrast defines the tumor, its extension along the clivus and into the middle fossa, and its relationship to the brainstem. A particularly important feature is whether a thin plane remains between tumor and brainstem or whether the two appear adherent — this predicts how much can be safely removed and is assessed before surgery rather than discovered during it.
The basilar artery and its small perforating branches supplying the brainstem often run within or behind the tumor. Their relationship is assessed on MRI and sometimes with angiography. Fine bone imaging defines the anatomy of the temporal bone, which determines which approaches are available.
Hearing testing, assessment of facial sensation and movement, and swallowing evaluation establish a baseline. Because preserving these functions is the primary goal, knowing precisely where they stand beforehand is essential to judging the result.
WHY LOCATION MATTERS
Why Location Matters in Petroclival Meningioma
Petroclival meningiomas sit deep at the skull base beside the brainstem, cranial nerves, and major arteries, making preservation of neurologic function the central treatment priority.
Where it sits
At the junction of the petrous bone and clivus, deep in front of and beside the brainstem.
What it can affect
Eye movement, facial sensation, hearing, balance, swallowing, voice, and coordination through involvement of multiple cranial nerves.
Why it matters for treatment
Because critical nerves and arteries may be tightly involved, planned subtotal removal plus focused radiation can sometimes offer a safer balance than complete resection.
Treatment
Some worsening of balance and of facial numbness is common in the early weeks and usually improves. Swallowing is assessed before eating resumes when the lower nerves have been involved. Focused radiation to residual tumor is planned according to how the remainder behaves on follow-up imaging, and surveillance continues for many years.
At Atlantic Brain and Spine, these cases are reviewed by a multidisciplinary skull base and brain tumor team to determine the approach that offers the best balance of tumor control and preservation of neurological function. Our Skull Base Surgery Center has been designated a Multidisciplinary Team of Distinction by the North American Skull Base Society, recognizing an established multidisciplinary approach to skull base care.
TREATMENT PLANNING
How Treatment Is Planned for Petroclival Meningioma
The safest strategy depends on the tumor’s exact anatomy, the structures it involves, and the goals of treatment.
01
Function Before Complete Removal
The most important thing to understand about these tumors is that complete removal is often not the goal of surgery. Instead, multimodality treatment is often the most effective and safest approach. The nerves for facial sensation, eye movement, hearing, and swallowing are draped across and through the tumor, and the brainstem lies immediately behind it. Removing the last portion of tumor adherent to those structures causes deficits that affect daily life permanently, and does so without a proportionate gain in tumor control. The established modern strategy is to remove as much as can be taken safely and to treat what remains with focused radiation.
02
Planned Radiation
Focused radiation controls the growth of residual meningioma in the large majority of cases over many years. Combining planned partial removal with radiation achieves comparable long-term control to attempted complete removal, with substantially better cranial nerve function.
03
Choosing the Surgical Route
Which surgical route is used depends on where the tumor extends. A retrosigmoid approach, behind the ear, is the most versatile and reaches tumors extending backward toward the cerebellum. A transpetrosal approach removes bone through the dense petrous bone to reach tumors sitting in front of the brainstem from the side rather than across it. Extended and combined approaches are used for tumors spanning both compartments. For selected tumors that are midline and largely in front of the brainstem, an endoscopic endonasal approach can be appropriate.
04
Real-Time Nerve Monitoring
During surgery continuous monitoring of the cranial nerves and of the pathways running through the brainstem is used throughout, and it directly informs how far the resection is carried. Where monitoring signals change, the resection stops at that point.
The Diagnosis-to-Treatment Pathway
1. Map the deep skull-base tumor
MRI with contrast defines extension along the clivus and middle fossa and shows the tumor’s relationship to the brainstem.
2. Assess arteries and bone anatomy
MRI, selected angiography, and fine bone imaging define the basilar artery, perforating vessels, and temporal-bone anatomy.
3. Establish cranial-nerve function
Hearing, facial sensation and movement, swallowing, balance, and other cranial-nerve functions are documented before treatment.
4. Set the treatment goal
The team weighs tumor control against preservation of neurologic function; complete removal is not always the safest objective.
5. Combine surgery and radiation when appropriate
A tailored skull-base operation may remove the safely accessible tumor, with focused radiation used for residual disease when indicated.
6. Continue long-term surveillance
Cranial-nerve recovery and residual tumor are monitored with clinical follow-up and MRI for many years.
Frequently Asked Questions
A petroclival meningioma arises deep at the skull base near the clivus and petrous bone, where it can contact the brainstem, basilar artery, and multiple cranial nerves.
Symptoms can include double vision, facial numbness, hearing or balance problems, facial weakness, swallowing difficulty, or other cranial-nerve deficits depending on the tumor’s size and direction of growth.
These tumors can surround cranial nerves and critical blood vessels. In some cases, leaving a small amount of tumor behind provides a better balance between long-term tumor control and preservation of neurologic function.
Focused radiation may be used for selected smaller tumors, for growth after observation, or for residual tumor intentionally left behind after surgery.
Petroclival meningiomas can require prolonged surveillance because residual tumor may remain stable for years or may later grow. MRI and cranial-nerve examinations help guide any additional treatment.
Specialists Who Treat Petroclival Meningiomas
Meningioma care at Atlantic Brain and Spine is provided by neurosurgeons with specialized expertise in brain and skull base tumors, with treatment tailored to the tumor’s location and nearby neurological structures.
Related Articles
View All Articles
An Unexpected Brain Tumor Diagnosis—and a Remarkable Recovery
After an unexpected meningioma diagnosis, Jim Van Arsdale turned to Yaron A. Moshel, MD, PhD, for brain tumor…
Still Running: How Brain Surgery Got a Glioblastoma Patient Back in the Race
At 77, Tom Brand was diagnosed with glioblastoma after losing his ability to speak. Following advanced brain surgery…
Brain Surgery Saved Her Life – Now She Saves Others as She Stands With Ukraine
After life-saving brain tumor surgery, Mariya Martynenko transformed her recovery into a mission—supporting Ukrainian refugees, veterans, and frontline…
It Takes a Team: How Collaborative Care Treated a Brain Tumor
When troubling symptoms turned out to be a brain tumor, Chris found expert, collaborative care at Atlantic Brain…
